Phase 0 clinical trials: theoretical and practical implications in oncologic drug development
Preciosa M ColomaDepartment of Medical Informatics, Erasmus MC University Medical Center, Rotterdam, The NetherlandsAbstract: Drug discovery and development has become a risky, expensive, and protracted process, with the cost of introducing a new drug to the market going as high as US$2 billion and...
Main Author: | Coloma PM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-10-01
|
Series: | Open Access Journal of Clinical Trials |
Online Access: | http://www.dovepress.com/phase-0-clinical-trials-theoretical-and-practical-implications-in-onco-a14715 |
Similar Items
-
Phase 0 clinical trials in oncology new drug development
by: Umesh Chandra Gupta, et al.
Published: (2011-01-01) -
Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
by: Lauren A. Marcath, et al.
Published: (2018-11-01) -
The design, analysis and application of mouse clinical trials in oncology drug development
by: Sheng Guo, et al.
Published: (2019-07-01) -
Theory and practice of clinical trials in oncology and hematology
by: N. V. Zhukov
Published: (2016-08-01) -
Participant experiences in phase I pediatric oncology clinical trials
by: Crane, Stacey M.
Published: (2017)